Covance Is Now Labcorp Clinical Trials

We are one global company innovating for millions – together, continuing to bring you more advanced medical breakthroughs.

Last Chance to Screen

8470-451 G8 Group 8

Back To Current Studies

Last Chance to Screen

Study Number

8470-451 G8

Group

Group 8

Gender

both

Age

18 - 55

Location

Daytona Beach, Florida

Compensation

$9,450

Study Dates

Feb. 01 - Jun. 21, 2022

Additional Information

This is a research study for an investigational drug being developed for the preventative treatment of migraine headaches.

The purpose of this study is to measure how much of the study drug gets into the bloodstream, and how long it takes the body to get rid of it, when given in two different formulations. In addition, the safety and tolerability of the study drugs will be evaluated.

• Healthy Non-Smoking Adults, ages 18-55

• BMI (body mass index) 18.5-30

• Trial involves 3 nights and 10 follow up visits

• Compensation up to $9,450 may be provided for time and participation

Details

Call Now to Schedule Your Screening Appointment! 

 

Group 8

Check-In: Feb 1
Check-Out: Feb 4

Follow-up Visit: Feb 8

Follow-up Visit: Feb 15

Follow-up Visit: Feb 22

Follow-up Visit: Mar 1

Follow-up Visit: Mar 15

Follow-up Visit: Mar 29

Follow-up Visit: Apr 12

Follow-up Visit: Apr 26

Follow-up Visit: May 24

Follow-up Visit: Jun 21

 

Calculate Your BMI!

Your Height:
ft / in
Your Weight:
lbs
Select Measurement System:

Your BMI: result